Page URL:

Charlott Repschlager

Charlott Repschlager is a Volunteer Writer at BioNews. She is studying for a PhD at King's College London's Institute of Psychiatry, Psychology & Neuroscience, where her research focuses on identifying pathological changes in mouse models of neuronal ceroid lipofuscinosis, a rare neurodegenerative disease in children and young adults. Previously, she studied Human and Medical Science at the University of Westminster.

BioNews Comment articles written by Charlott Repschlager:
Page 1 of 1
How do we deal with big genomic data responsibly?
9 July 2018 - by Charlott Repschlager
The latest event organised by the Progress Educational Trust, 'With great genomic data comes great responsibility', came at a perfect time... [Read More]

BioNews Review articles written by Charlott Repschlager:
Page 1 of 1
Video Review: The Code by Retro Report with STAT
8 May 2018 - by Charlott Repschlager
Personalised medicine is a topic that pops up frequently in the news and has been for what feels like a long time... [Read More]

BioNews News articles written by Charlott Repschlager:
Page 1 of 2
Prostate cancer gene mutation raises risk of death by threefold
13 May 2019 - by Charlott Repschlager
A mutation that raises a prostate cancer patient's risk of death by threefold has been discovered... [Read More]
Pilot study launched for cancer breath test
7 January 2019 - by Charlott Repschlager
A pilot study on a breath test to detect cancer has been launched in the UK... [Read More]
Epigenetics may give 'universal' cancer test
10 December 2018 - by Charlott Repschlager
Australian researchers have developed a cancer test, which could potentially detect cancerous DNA in blood and tissue samples in under 10 minutes... [Read More]
Genome editing treats inherited liver disease PKU in mice
22 October 2018 - by Charlott Repschlager
Researchers have successfully used genome editing in mice to correct a genetic mutation that causes the liver disease phenylketonuria (PKU)... [Read More]
Cancer-related gene variations often reclassified, shows study
1 October 2018 - by Charlott Repschlager
Almost a quarter of all cancer gene test variations were amended due to reclassification over the course of a decade, found a new study... [Read More]
Three patients die from breast cancer through organ donation
17 September 2018 - by Charlott Repschlager
Four organ recipients developed cancer after doctors did not detect breast cancer in an organ donor... [Read More]
Genome editing relieves muscular dystrophy in dogs
3 September 2018 - by Charlott Repschlager
Dogs with Duchenne muscular dystrophy (DMD) have been treated using genome editing, a study in Science reports... [Read More]
Genetic screening of embryos makes no difference to births
13 August 2018 - by Charlott Repschlager
Pre-implantation genetic testing of embryos does not improve IVF birth rates in older women, found the largest study of its kind yet... [Read More]
Fertility treatment doesn't boost womb or breast cancer risk
16 July 2018 - by Charlott Repschlager
Assisted reproduction techniques such as IVF do not increase a woman's risk of developing womb or breast cancer, a new study has found... [Read More]
Genetic test identifies very highest risk men for prostate cancer
18 June 2018 - by Charlott Repschlager
Sixty-three novel gene variants linked to prostate cancer in men have been discovered... [Read More]